Literature DB >> 33668216

Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses.

Lila M Zarski1, Kim S Giessler1, Sarah I Jacob1, Patty Sue D Weber2, Allison G McCauley1, Yao Lee1, Gisela Soboll Hussey1.   

Abstract

Equine herpesvirus-1 is the cause of respiratory disease, abortion, and equine herpesvirus myeloencephalopathy (EHM) in horses worldwide. EHM affects as many as 14% of infected horses and a cell-associated viremia is thought to be central for EHM pathogenesis. While EHM is infrequent in younger horses, up to 70% of aged horses develop EHM. The aging immune system likely contributes to EHM pathogenesis; however, little is known about the host factors associated with clinical EHM. Here, we used the "old mare model" to induce EHM following EHV-1 infection. Peripheral blood mononuclear cells (PBMCs) of horses prior to infection and during viremia were collected and RNA sequencing with differential gene expression was used to compare the transcriptome of horses that did (EHM group) and did not (non-EHM group) develop clinical EHM. Interestingly, horses exhibiting EHM did not show respiratory disease, while non-EHM horses showed significant respiratory disease starting on day 2 post infection. Multiple immune pathways differed in EHM horses in response to EHV-1. These included an upregulation of IL-6 gene expression, a dysregulation of T-cell activation through AP-1 and responses skewed towards a T-helper 2 phenotype. Further, a dysregulation of coagulation and an upregulation of elements in the progesterone response were observed in EHM horses.

Entities:  

Keywords:  EHM; EHV-1; PBMC; RNA sequencing; gene expression; herpesvirus; horse; microRNA; pathogenesis; transcriptomics

Year:  2021        PMID: 33668216     DOI: 10.3390/v13030356

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  4 in total

1.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

2.  Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Authors:  Côme J Thieulent; Gabrielle Sutton; Marie-Pierre Toquet; Samuel Fremaux; Erika Hue; Christine Fortier; Alexis Pléau; Alain Deslis; Stéphane Abrioux; Edouard Guitton; Stéphane Pronost; Romain Paillot
Journal:  Pathogens       Date:  2022-05-04

3.  Clinical impact, diagnosis and control of Equine Herpesvirus-1 infection in Europe.

Authors:  Andrea Carvelli; Søren Saxmose Nielsen; Romain Paillot; Alessandro Broglia; Lisa Kohnle
Journal:  EFSA J       Date:  2022-04-06

4.  Equine Herpesvirus Type 4 (EHV-4) Outbreak in Germany: Virological, Serological, and Molecular Investigations.

Authors:  Selvaraj Pavulraj; Kathrin Eschke; Jana Theisen; Stephanie Westhoff; Gitta Reimers; Sandro Andreotti; Nikolaus Osterrieder; Walid Azab
Journal:  Pathogens       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.